ThermoFisher’s most recent trend suggests a bullish bias. One trading opportunity on ThermoFisher is a Bull Put Spread using a strike $155.00 short put and a strike $145.00 long put offers a potential 13.64% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $155.00 by expiration. The full premium credit of $1.20 would be kept by the premium seller. The risk of $8.80 would be incurred if the stock dropped below the $145.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for ThermoFisher is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for ThermoFisher is bullish.
The RSI indicator is at 79.61 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for ThermoFisher
Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc.
Tue, 14 Feb 2017 23:15:00 GMT
Business Wire – Thermo Fisher Scientific Inc. , the world leader in serving science, today completed its previously announced acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction.
Thermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions, Inc.
Mon, 13 Feb 2017 14:15:00 GMT
Business Wire – Thermo Fisher Scientific Inc. , the world leader in serving science, today announced that its pending acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction, has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific
Wed, 08 Feb 2017 21:53:03 GMT
Weitz Investment Looks to Visa (V), Amazon (AMZN), Others for Big Returns After Subpar 2016
Tue, 07 Feb 2017 13:57:52 GMT
Why the state’s two biggest medical device firms have gained $4.5B in market cap this week
Thu, 02 Feb 2017 20:10:09 GMT
Also on Market Tamer…
Follow Us on Facebook